CAROL K TWEED

Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology ANNAPOLIS, MD NPI 1649219155

General Payments — all program years on this page

$111,558.14

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 111
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $13,034.29 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $5,715.0717
2019 $4,841.0915
2020 $6,525.005
2021 $9,532.099
2022 $42,044.2426
2023 $29,866.3622
2024 $13,034.2917

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087436798 Novartis Pharmaceuticals Corporation $2,362.50 04/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1087436800 Novartis Pharmaceuticals Corporation $34.39 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087436802 Novartis Pharmaceuticals Corporation $125.33 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089493040 Daiichi Sankyo Inc. $1,370.00 04/03/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089493042 Daiichi Sankyo Inc. $18.74 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101079639 Celgene Corporation $16.30 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104333146 AstraZeneca Pharmaceuticals LP $3,280.00 12/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1106255697 ABBVIE INC. $23.66 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116341500 GlaxoSmithKline, LLC. $34.22 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116524846 GlaxoSmithKline, LLC. $27.84 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116666217 GlaxoSmithKline, LLC. $33.79 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131481253 PFIZER INC. $125.00 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131481257 PFIZER INC. $4,200.00 04/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1131481261 PFIZER INC. $850.68 04/10/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133600047 Gilead Sciences, Inc. $420.00 02/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133829439 Gilead Sciences, Inc. $88.67 06/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141964941 Merck Sharp & Dohme LLC $23.17 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.